Axel Bolte

Insider Reports History

Location
South Plainfield, NJ
Signature
/s/ Sanjay Subramanian, as attorney-in-fact for Axel Bolte
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Axel Bolte:

Form 4 holding Director

Inozyme Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
01 Jul 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

IVERIC bio, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
11 Jul 2023
Price
$39.45
Ownership
Direct
Form 4 holding Director

IVERIC bio, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
11 Jul 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

IVERIC bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
11 Jul 2023
Price
$10.03
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Axel Bolte

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .